Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesAntiplatelet drugs and the perioperative period: What every urologist needs to know
Indian Journal of Urology, 10/05/09
Vasudeva P et al. – Although antiplatelet drugs may be discontinued in patients at a low risk for an arterial thrombotic event, they must be continued in patients where the risks of bleeding and complications related to excessive bleeding are less than the risks of developing arterial thrombosis.
Related Articles
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
Vascular Health and Risk Management, 11/10/09
Relevance Score: 66%
Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09
Relevance Score: 66%
New antiplatelet agents: Why they are needed
European Journal of Internal Medicine, 11/09/09
Relevance Score: 65%
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Relevance Score: 65%
Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug
Atherosclerosis, 10/07/09
Relevance Score: 65%
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
C-Reactive Protein and Cardiovascular Diseases-Is it Ready for Primetime
The American Journal of the Medical Sciences, 12/17/09
Infarct Remodeling Process During Long-term Follow-up After Reperfused Acute Myocardial Infarction
The American Journal of the Medical Sciences, 12/17/09
Interaction Between Cigarette Smoking and High-Sensitivity C-Reactive Protein in the Development of Coronary Vasospasm in Patients Without Hemodynamically Significant Coronary Artery Disease
The American Journal of the Medical Sciences, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor